Tysabri news is good for ISEQ

The ISEQ index climbed 121.78 points to 7894.62 this morning.

Tysabri news is good for ISEQ

The ISEQ index climbed 121.78 points to 7894.62 this morning.

Elan soared €2.40 (21.2%) to €13.70 following news that multiple sclerosis drug Tysabri is expected to be approved to go back on sale shortly. It was the morning’s busiest share.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited